Yale: Using the immune system as a window into your current and future health

For many conditions including immune-related ones, genetics often explains only a small fraction of the differences between ...
Le Lézard

BIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated ...

UCB, a global biopharmaceutical company, today announced new three-year data from Phase 3 trials, and their open-label extensions, investigating BIMZELX® (bimekizumab-bkzx) in adults with active ...